68Ga-UZBRU-VHH2 clinical trials

Phase II study to assess in vivo imaging of MMR-expressing macrophages in cardiac sarcoidosis using 68Ga-NOTA-Anti-MMR-VHH2 Positron Emission Tomography (PET).

This study uses a special scan to see if a new tracer can find active heart sarcoidosis. It helps doctors understand if this scan can pinpoint areas of inflammation and how it compares to other tests, aiming for better diagnosis and treatment watching.